FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ATP6V0A1-NBR1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ATP6V0A1-NBR1
FusionPDB ID: 8087
FusionGDB2.0 ID: 8087
HgeneTgene
Gene symbol

ATP6V0A1

NBR1

Gene ID

535

4077

Gene nameATPase H+ transporting V0 subunit a1NBR1 autophagy cargo receptor
SynonymsATP6N1|ATP6N1A|Stv1|VPP1|Vph1|a11A1-3B|IAI3B|M17S2|MIG19
Cytomap

17q21.2

17q21.31

Type of geneprotein-codingprotein-coding
DescriptionV-type proton ATPase 116 kDa subunit a isoform 1V-type proton ATPase 116 kDa subunit aATPase, H+ transporting, lysosomal V0 subunit a1ATPase, H+ transporting, lysosomal non-catalytic accessory protein 1 (110/116kD)H(+)-transporting two-sector ATPase, next to BRCA1 gene 1 proteinB-box proteincell migration-inducing gene 19 proteinmembrane component, chromosome 17, surface marker 2 (ovarian carcinoma antigen CA125)migration-inducing protein 19neighbor of BRCA1 gene 1
Modification date2020032420200313
UniProtAcc

Q93050

Main function of 5'-partner protein: FUNCTION: Required for assembly and activity of the vacuolar ATPase. Potential role in differential targeting and regulation of the enzyme for a specific organelle (By similarity). {ECO:0000250}.

Q14596

Main function of 5'-partner protein: FUNCTION: Acts probably as a receptor for selective autophagosomal degradation of ubiquitinated targets. {ECO:0000269|PubMed:19250911}.
Ensembl transtripts involved in fusion geneENST idsENST00000264649, ENST00000343619, 
ENST00000393829, ENST00000537728, 
ENST00000544137, ENST00000546249, 
ENST00000585525, ENST00000587797, 
ENST00000341165, ENST00000389312, 
ENST00000422280, ENST00000542611, 
ENST00000589872, ENST00000590996, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score20 X 17 X 9=30606 X 7 X 5=210
# samples 227
** MAII scorelog2(22/3060*10)=-3.79795622405535
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/210*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ATP6V0A1 [Title/Abstract] AND NBR1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ATP6V0A1 [Title/Abstract] AND NBR1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ATP6V0A1(40659645)-NBR1(41338267), # samples:1
Anticipated loss of major functional domain due to fusion event.ATP6V0A1-NBR1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ATP6V0A1-NBR1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ATP6V0A1-NBR1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ATP6V0A1-NBR1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneNBR1

GO:0016236

macroautophagy

19250911



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:40659645/chr17:41338267)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ATP6V0A1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NBR1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000393829ATP6V0A1chr1740659645+ENST00000341165NBR1chr1741338267+658822797449721632
ENST00000393829ATP6V0A1chr1740659645+ENST00000422280NBR1chr1741338267+658622797449721632
ENST00000393829ATP6V0A1chr1740659645+ENST00000542611NBR1chr1741338267+472822797446481524
ENST00000393829ATP6V0A1chr1740659645+ENST00000590996NBR1chr1741338267+542022797449721632
ENST00000393829ATP6V0A1chr1740659645+ENST00000389312NBR1chr1741338267+658622797449721632
ENST00000393829ATP6V0A1chr1740659645+ENST00000589872NBR1chr1741338267+510022797448851603
ENST00000546249ATP6V0A1chr1740659645+ENST00000341165NBR1chr1741338267+658822797449721632
ENST00000546249ATP6V0A1chr1740659645+ENST00000422280NBR1chr1741338267+658622797449721632
ENST00000546249ATP6V0A1chr1740659645+ENST00000542611NBR1chr1741338267+472822797446481524
ENST00000546249ATP6V0A1chr1740659645+ENST00000590996NBR1chr1741338267+542022797449721632
ENST00000546249ATP6V0A1chr1740659645+ENST00000389312NBR1chr1741338267+658622797449721632
ENST00000546249ATP6V0A1chr1740659645+ENST00000589872NBR1chr1741338267+510022797448851603
ENST00000537728ATP6V0A1chr1740659645+ENST00000341165NBR1chr1741338267+642521164048091589
ENST00000537728ATP6V0A1chr1740659645+ENST00000422280NBR1chr1741338267+642321164048091589
ENST00000537728ATP6V0A1chr1740659645+ENST00000542611NBR1chr1741338267+456521164044851481
ENST00000537728ATP6V0A1chr1740659645+ENST00000590996NBR1chr1741338267+525721164048091589
ENST00000537728ATP6V0A1chr1740659645+ENST00000389312NBR1chr1741338267+642321164048091589
ENST00000537728ATP6V0A1chr1740659645+ENST00000589872NBR1chr1741338267+493721164047221560
ENST00000264649ATP6V0A1chr1740659645+ENST00000341165NBR1chr1741338267+657322643849571639
ENST00000264649ATP6V0A1chr1740659645+ENST00000422280NBR1chr1741338267+657122643849571639
ENST00000264649ATP6V0A1chr1740659645+ENST00000542611NBR1chr1741338267+471322643846331531
ENST00000264649ATP6V0A1chr1740659645+ENST00000590996NBR1chr1741338267+540522643849571639
ENST00000264649ATP6V0A1chr1740659645+ENST00000389312NBR1chr1741338267+657122643849571639
ENST00000264649ATP6V0A1chr1740659645+ENST00000589872NBR1chr1741338267+508522643848701610
ENST00000585525ATP6V0A1chr1740659645+ENST00000341165NBR1chr1741338267+641521063047991589
ENST00000585525ATP6V0A1chr1740659645+ENST00000422280NBR1chr1741338267+641321063047991589
ENST00000585525ATP6V0A1chr1740659645+ENST00000542611NBR1chr1741338267+455521063044751481
ENST00000585525ATP6V0A1chr1740659645+ENST00000590996NBR1chr1741338267+524721063047991589
ENST00000585525ATP6V0A1chr1740659645+ENST00000389312NBR1chr1741338267+641321063047991589
ENST00000585525ATP6V0A1chr1740659645+ENST00000589872NBR1chr1741338267+492721063047121560
ENST00000343619ATP6V0A1chr1740659645+ENST00000341165NBR1chr1741338267+654422353049281632
ENST00000343619ATP6V0A1chr1740659645+ENST00000422280NBR1chr1741338267+654222353049281632
ENST00000343619ATP6V0A1chr1740659645+ENST00000542611NBR1chr1741338267+468422353046041524
ENST00000343619ATP6V0A1chr1740659645+ENST00000590996NBR1chr1741338267+537622353049281632
ENST00000343619ATP6V0A1chr1740659645+ENST00000389312NBR1chr1741338267+654222353049281632
ENST00000343619ATP6V0A1chr1740659645+ENST00000589872NBR1chr1741338267+505622353048411603
ENST00000544137ATP6V0A1chr1740659645+ENST00000341165NBR1chr1741338267+549611871438801288
ENST00000544137ATP6V0A1chr1740659645+ENST00000422280NBR1chr1741338267+549411871438801288
ENST00000544137ATP6V0A1chr1740659645+ENST00000542611NBR1chr1741338267+363611871435561180
ENST00000544137ATP6V0A1chr1740659645+ENST00000590996NBR1chr1741338267+432811871438801288
ENST00000544137ATP6V0A1chr1740659645+ENST00000389312NBR1chr1741338267+549411871438801288
ENST00000544137ATP6V0A1chr1740659645+ENST00000589872NBR1chr1741338267+400811871437931259

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000393829ENST00000341165ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001762140.99982387
ENST00000393829ENST00000422280ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001777380.9998223
ENST00000393829ENST00000542611ATP6V0A1chr1740659645+NBR1chr1741338267+0.0002446060.99975544
ENST00000393829ENST00000590996ATP6V0A1chr1740659645+NBR1chr1741338267+0.0004474360.99955255
ENST00000393829ENST00000389312ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001777380.9998223
ENST00000393829ENST00000589872ATP6V0A1chr1740659645+NBR1chr1741338267+0.000415560.9995845
ENST00000546249ENST00000341165ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001762140.99982387
ENST00000546249ENST00000422280ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001777380.9998223
ENST00000546249ENST00000542611ATP6V0A1chr1740659645+NBR1chr1741338267+0.0002446060.99975544
ENST00000546249ENST00000590996ATP6V0A1chr1740659645+NBR1chr1741338267+0.0004474360.99955255
ENST00000546249ENST00000389312ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001777380.9998223
ENST00000546249ENST00000589872ATP6V0A1chr1740659645+NBR1chr1741338267+0.000415560.9995845
ENST00000537728ENST00000341165ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001579840.99984205
ENST00000537728ENST00000422280ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001592070.99984074
ENST00000537728ENST00000542611ATP6V0A1chr1740659645+NBR1chr1741338267+0.0002074440.9997925
ENST00000537728ENST00000590996ATP6V0A1chr1740659645+NBR1chr1741338267+0.0003971940.99960285
ENST00000537728ENST00000389312ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001592070.99984074
ENST00000537728ENST00000589872ATP6V0A1chr1740659645+NBR1chr1741338267+0.0003560610.9996439
ENST00000264649ENST00000341165ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001785090.9998215
ENST00000264649ENST00000422280ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001800590.99981993
ENST00000264649ENST00000542611ATP6V0A1chr1740659645+NBR1chr1741338267+0.0002542490.9997458
ENST00000264649ENST00000590996ATP6V0A1chr1740659645+NBR1chr1741338267+0.0004610120.999539
ENST00000264649ENST00000389312ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001800590.99981993
ENST00000264649ENST00000589872ATP6V0A1chr1740659645+NBR1chr1741338267+0.0004298890.9995701
ENST00000585525ENST00000341165ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001570670.9998429
ENST00000585525ENST00000422280ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001582860.9998417
ENST00000585525ENST00000542611ATP6V0A1chr1740659645+NBR1chr1741338267+0.0002064570.9997936
ENST00000585525ENST00000590996ATP6V0A1chr1740659645+NBR1chr1741338267+0.0003962240.9996038
ENST00000585525ENST00000389312ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001582860.9998417
ENST00000585525ENST00000589872ATP6V0A1chr1740659645+NBR1chr1741338267+0.0003551640.9996449
ENST00000343619ENST00000341165ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001666710.99983335
ENST00000343619ENST00000422280ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001681620.9998318
ENST00000343619ENST00000542611ATP6V0A1chr1740659645+NBR1chr1741338267+0.0002267050.9997733
ENST00000343619ENST00000590996ATP6V0A1chr1740659645+NBR1chr1741338267+0.0004178570.9995821
ENST00000343619ENST00000389312ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001681620.9998318
ENST00000343619ENST00000589872ATP6V0A1chr1740659645+NBR1chr1741338267+0.000385660.99961436
ENST00000544137ENST00000341165ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001527410.9998473
ENST00000544137ENST00000422280ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001542270.99984574
ENST00000544137ENST00000542611ATP6V0A1chr1740659645+NBR1chr1741338267+0.0002729660.9997271
ENST00000544137ENST00000590996ATP6V0A1chr1740659645+NBR1chr1741338267+0.0004755870.9995245
ENST00000544137ENST00000389312ATP6V0A1chr1740659645+NBR1chr1741338267+0.0001542270.99984574
ENST00000544137ENST00000589872ATP6V0A1chr1740659645+NBR1chr1741338267+0.0004303380.9995697

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ATP6V0A1-NBR1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide

Top

Potential FusionNeoAntigen Information of ATP6V0A1-NBR1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Potential FusionNeoAntigen Information of ATP6V0A1-NBR1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of ATP6V0A1-NBR1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ATP6V0A1-NBR1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score

Top

Vaccine Design for the FusionNeoAntigens of ATP6V0A1-NBR1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of ATP6V0A1-NBR1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample

Top

Potential target of CAR-T therapy development for ATP6V0A1-NBR1

check button Predicted 3D structure. We used RoseTTAFold.
51_ATP6V0A1-NBR1_t000_.e2e.pdb


check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000264649+1821389_407711839.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000264649+1821410_426711839.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000264649+1821442_471711839.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000264649+1821535_554711839.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000264649+1821573_593711839.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000264649+1821639_658711839.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000343619+1822389_407704838.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000343619+1822410_426704838.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000343619+1822442_471704838.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000343619+1822535_554704838.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000343619+1822573_593704838.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000343619+1822639_658704838.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000393829+1821389_407704832.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000393829+1821410_426704832.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000393829+1821442_471704832.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000393829+1821535_554704832.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000393829+1821573_593704832.0TransmembraneHelical
HgeneATP6V0A1chr17:40659645chr17:41338267ENST00000393829+1821639_658704832.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result
ATP6V0A1chr1740659645ENST00000264649NBR1chr1741338267ENST00000341165
ATP6V0A1chr1740659645ENST00000264649NBR1chr1741338267ENST00000542611
ATP6V0A1chr1740659645ENST00000264649NBR1chr1741338267ENST00000589872
ATP6V0A1chr1740659645ENST00000343619NBR1chr1741338267ENST00000341165
ATP6V0A1chr1740659645ENST00000343619NBR1chr1741338267ENST00000542611
ATP6V0A1chr1740659645ENST00000343619NBR1chr1741338267ENST00000589872
ATP6V0A1chr1740659645ENST00000537728NBR1chr1741338267ENST00000341165
ATP6V0A1chr1740659645ENST00000537728NBR1chr1741338267ENST00000542611
ATP6V0A1chr1740659645ENST00000537728NBR1chr1741338267ENST00000589872
ATP6V0A1chr1740659645ENST00000544137NBR1chr1741338267ENST00000341165
ATP6V0A1chr1740659645ENST00000544137NBR1chr1741338267ENST00000542611
ATP6V0A1chr1740659645ENST00000544137NBR1chr1741338267ENST00000589872

Top

Related Drugs to ATP6V0A1-NBR1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ATP6V0A1-NBR1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource